(ECNS) iShares MSCI China - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B2007 • China Region
ECNS: Chinese, Small-Cap, Stocks, Equities
The iShares MSCI China Small-Cap ETF (NYSE ARCA: ECNS) is a U.S.-listed exchange-traded fund designed to provide exposure to the small-capitalization segment of the Chinese equity markets. The fund primarily invests in H-shares and B-shares, which are Chinese companies listed on the Hong Kong and Shanghai/Shenzhen stock exchanges, respectively. By tracking the MSCI China Small Cap Index, the ETF aims to replicate the performance of small-cap Chinese companies, offering investors a targeted way to access this specific market segment. The funds portfolio is constructed using a market capitalization-weighted approach, with a focus on maintaining a minimum of 80% of its assets in securities that align with the underlying index or exhibit substantially similar economic characteristics.
From a technical perspective, ECNS is currently trading above its 20-day, 50-day, and 200-day moving averages, indicating bullish momentum in the near term. The average true range (ATR) of 0.53 suggests relatively stable price movements, with moderate volatility expected in the coming weeks. Based on the current trend, the fund is likely to maintain its upward trajectory in the next three months, supported by strengthening economic fundamentals in China and increased investor appetite for small-cap equities. However, risks such as regulatory changes in China and broader market volatility could impact performance. With assets under management (AUM) of $67.64 million, ECNS remains a niche but focused vehicle for accessing the small-cap segment of the Chinese market.
Additional Sources for ECNS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ECNS ETF Overview
Market Cap in USD | 62m |
Category | China Region |
TER | 0.59% |
IPO / Inception | 2010-09-28 |
ECNS ETF Ratings
Growth Rating | -13.3 |
Fundamental | - |
Dividend Rating | 39.9 |
Rel. Strength | 13.1 |
Analysts | - |
Fair Price Momentum | 26.92 USD |
Fair Price DCF | - |
ECNS Dividends
Dividend Yield 12m | 5.81% |
Yield on Cost 5y | 5.27% |
Annual Growth 5y | -2.86% |
Payout Consistency | 85.7% |
ECNS Growth Ratios
Growth Correlation 3m | 8.9% |
Growth Correlation 12m | 64.3% |
Growth Correlation 5y | -79.2% |
CAGR 5y | -1.02% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | 0.12 |
Alpha | 16.67 |
Beta | 0.560 |
Volatility | 35.89% |
Current Volume | 8.6k |
Average Volume 20d | 16.6k |
As of April 25, 2025, the stock is trading at USD 27.51 with a total of 8,590 shares traded.
Over the past week, the price has changed by +7.08%, over one month by -2.20%, over three months by +9.91% and over the past year by +23.87%.
Neither. Based on ValueRay Analyses, iShares MSCI China is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -13.27 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ECNS as of April 2025 is 26.92. This means that ECNS is currently overvalued and has a potential downside of -2.14%.
iShares MSCI China has no consensus analysts rating.
According to ValueRays Forecast Model, ECNS iShares MSCI China will be worth about 29.7 in April 2026. The stock is currently trading at 27.51. This means that the stock has a potential upside of +7.82%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.7 | 7.8% |